Safety and Efficacy of Pegylated Liposomal Doxorubicin-based Adjuvant Chemotherapy in Patients with Stage I-III Triple-negative Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2015
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Dec 2015 New trial record